37-7-106. Pharmacist prescribing authority -- exception.
309 words·~1 min read·
/mt/title-37/chapter-7/part-1/37-7-106·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
37-7-106 . Pharmacist prescribing authority -- exception.
(1)A pharmacist may prescribe a drug or device for a legitimate medical purpose as allowed under this section for a person with whom the pharmacist has a patient-prescriber relationship.
(2)A pharmacist shall establish the patient-prescriber relationship through a documented patient evaluation that is adequate to:
(a)establish diagnoses, if the drug or device is being prescribed pursuant to subsection (3)(b); and
(b)identify underlying conditions and contraindications to the treatment.
(3)A pharmacist's prescribing authority is limited to drugs and devices that are prescribed for conditions that:
(a)do not require a new diagnosis; or
(i)are minor and generally self-limiting;
(ii)are diagnosed by or for which clinical decisions are made using a test that is waived under the federal clinical laboratory improvement amendments of 1988; or
(iii)are patient emergencies.
(4)A pharmacist may:
(a)prescribe only the drugs or devices for which the pharmacist is educationally prepared and for which competency has been achieved and maintained; and
(b)bill only for assessment services that were necessary, based on the pharmacist's professional judgment, for the pharmacist's decision to prescribe a drug or device pursuant to this section.
(5)A pharmacist may not prescribe a controlled substance or an abortion-inducing drug as that term is defined in 50-20-703 .
(6)A pharmacist prescribing a drug or device pursuant to this section shall:
(a)recognize the limits of the pharmacist's knowledge and experience and consult with and refer to other health care providers as appropriate; and
(b)maintain documentation sufficient to justify the care provided, including but not limited to the:
(i)information collected as part of the patient record;
(ii)prescription record;
(iii)provider notification; and
(iv)follow-up care plan.
(7)This section does not apply to a pharmacist who is operating within a collaborative pharmacy practice agreement.